Quest Diagnostics Incorporated (DGX): Price and Financial Metrics

Quest Diagnostics Incorporated (DGX)

Today's Latest Price: $76.72 USD

3.58 (-4.46%)

Updated Apr 1 1:50pm

Add DGX to Watchlist
Sign Up

Overall POWR Rating

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

Ranked of 58 in Medical - Diagnostics/Research

See all "A" rated Strong Buy stocks

DGX Stock Summary

  • Quest Diagnostics Inc's market capitalization of $10,580,317,791 is ahead of 88.7% of US-listed equities.
  • Of note is the ratio of Quest Diagnostics Inc's sales and general administrative expense to its total operating expenses; 86.27% of US stocks have a lower such ratio.
  • The volatility of Quest Diagnostics Inc's share price is greater than that of just 5.47% US stocks with at least 200 days of trading history.
  • Stocks that are quantitatively similar to DGX, based on their financial statements, market capitalization, and price volatility, are SWK, BRO, WRK, HII, and MKC.
  • Visit DGX's SEC page to see the company's official filings. To visit the company's web site, go to
DGX Daily Price Range
DGX 52-Week Price Range

DGX Stock Price Chart More Charts

DGX Price/Volume Stats

Current price $76.72 52-week high $118.58
Prev. close $80.30 52-week low $73.21
Day low $74.11 Volume 1,523,826
Day high $77.92 Avg. volume 1,573,976
50-day MA $102.31 Dividend yield 2.64%
200-day MA $103.24 Market Cap 10.24B

Quest Diagnostics Incorporated (DGX) Company Bio

Quest Diagnostics provides diagnostic testing information services in the United States and internationally. The company offers clinical testing services, such as routine testing, gene-based and esoteric testing, anatomic pathology services, and drugs-of-abuse testing, as well as related services and insights; laboratory testing services for new drugs, vaccines, and medical devices, analytic, on-site prevention, and wellness services, and risk assessment services for the life insurance industry. The company was founded in 1967 and is founded in Madison, New Jersey.

DGX Price Forecast Based on DCF Valuation

Current PriceDCF Fair Value Target:Forecasted Gain:

The table below illustrates the output of a discounted cash flow forecast using a variety of scenarios for Quest Diagnostics Inc. To summarize, we found that Quest Diagnostics Inc ranked in the 54th percentile in terms of potential gain offered. More precisely, our analysis suggests the stock is undervalued by approximately 73.17% on a DCF basis. In terms of the factors that were most noteworthy in this DCF analysis for DGX, they are:

  • Quest Diagnostics Inc's weighted average cost of capital (WACC) is 6%; for context, that number is higher than only 15.67% of tickers in our DCF set.
  • Relative to other stocks in its sector (Healthcare), Quest Diagnostics Inc has a reliance on debt greater than 71.34% of them.

Terminal Growth Rate in Free Cash FlowReturn Relative to Current Share Price

For other companies in the Healthcare that have a similar discounted cashflow valuation profile (and ensuing price forecasts) as DGX, try SNY, FONR, NVST, DVA, and IONS.

DGX Latest News Stream

Event/TimeNews Detail
Loading, please wait...

DGX Latest Social Stream

Loading social stream, please wait...

View Full DGX Social Stream

DGX Price Returns

1-mo -31.57%
3-mo -27.08%
6-mo -26.39%
1-year -13.83%
3-year -17.07%
5-year 12.06%
YTD -27.80%
2019 31.13%
2018 -13.84%
2017 9.16%
2016 31.90%
2015 8.37%

DGX Dividends

Ex-Dividend DateTypePayout AmountChange
Loading, please wait...
View Full DGX Dividend History

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.8437 seconds.